This randomized trial compares the effects of initial treatment with intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity over 24 weeks among adults with vitreous hemorrhage from proliferative diabetic retinopathy.
This international study pooled individual-participant data from several long-term prospective studies to evaluate the relationship between depressive symptoms and incident cardiovascular disease.
This cohort study assesses adherence to evidence-based fractional flow reserve (FFR) thresholds for percutaneous coronary intervention in Canada between 2013 and 2018, and associations of percutaneous coronary intervention with major adverse clinical outcomes for patients with FFR measures above and beneath ischemic thresholds.
This study uses commercial and Medicare Advantage claims data to compare medication fills, outpatient visits, and urine tests for opioid use disorder in January-May 2020 vs 2019.
This study examined outpatient buprenorphine dispensing patterns in Texas before vs after the Drug Enforcement Administration temporarily relaxed outpatient buprenorphine prescribing regulations in March 2020 in response to the COVID-19 pandemic.
This 2020 US Preventive Services Task Force Recommendation Statement recommends screening for HBV infection in adolescents and adults at increased risk for infection (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B virus infection summarizes published evidence on the benefits and harms of screening and interventions for hepatitis B infection in nonpregnant adolescents and adults.
This Viewpoint discusses barriers to building trust between physicians and patients and offers recommendations to increase that trust, including minimizing emphasis on patient consumerism, promoting authentic partnerships, and accelerating select payment and delivery system reforms.
This Viewpoint discusses efforts that medical centers can take in rebuilding affordability-related trust and relationships with patients.
This Viewpoint discusses the declining trust in the US health care system, especially in the midst of the COVID-19 pandemic, and the importance that maintaining public trust should hold in the culture of health care organizations.
This Viewpoint describes transparency practices that could help physicians build trust with patients and model professionalism for students and trainees: clear and consistent disclosure of financial relationships, conflicts of interest, credentials, disciplinary actions, performance metrics, and personal information or experiences oriented toward improving patient outcomes.
This Viewpoint describes why health misinformation spreads, characterizes a broader set of misinformation types, and discusses solutions to this problem.
This Viewpoint discusses how human-centered design (HCD) that involves all stakeholders can improve patient trust in physicians and health care systems, describes its methods, and provides examples of its successful application.
In this narrative medicine essay, a critical care fellow returning to the ICU after burying her grandmother learns that grief does not conform to clinical schedules and efficiencies, having instead its own pace and melody, like the songs on violin she loved to performed for her beloved Gram.
This Medical Letter compares a newly approved fixed-dose combination pill comprising the sodium-glucose cotransporter 2 inhibitor empagliflozin, the dipeptidyl peptidase-4 inhibitor linagliptin, and extended-release metformin, with available formulations of each of the pill’s individual components for oral treatment of type 2 diabetes in adults.
This Medical News article discusses the top-viewed research articles published across the JAMA Network in the past year.
This JAMA Live Highlights feature provides comments about the coronavirus 2019 pandemic from experts in clinical medicine, public health, and health policy expressed during livestream interviews with JAMA Network Editor in Chief Howard Bauchner, MD.
This JAMA Patient Page reviews the US Preventive Services Task Force’s 2020 recommendation to screen for hepatitis B infection in adolescents and adults at increased risk (B recommendation).